GOSS surged 46.62% in 24 hours, with a 17.29% weekly gain, after a r/pennystocks user disclosed a 20,000-share purchase.
The user cited recent NFA approvals as a potential catalyst for the price move, targeting a $1 exit.
Gossamer Bio is a clinical-stage biopharma focused on seralutinib for pulmonary arterial hypertension (PAH).
Shares of 
The Reddit Post That Moved the Stock
A user on r/pennystocks announced they had purchased 20,000 shares of
The post's TL;DR summarized the thesis: "The author bought 20,000 shares of GOSS at $0.22, intending to hold until $1, citing recent NFA approvals as a potential catalyst for its recent price surge." This straightforward bullish narrative, combined with the stock's low absolute price, made it a natural target for speculative retail traders.
Why GOSS? The Company Behind the Ticker
Gossamer Bio is a clinical-stage biopharmaceutical company focused on developing treatments for pulmonary arterial hypertension (PAH) and other rare lung diseases. Its lead candidate, seralutinib, is an inhaled drug designed to address the underlying pathology of PAH. The company's pipeline and regulatory milestones have historically driven volatility, making it a frequent topic on penny stock forums.
Retail Sentiment and Engagement
The r/pennystocks community showed strong bullish sentiment on GOSS, with an average sentiment score of 0.74 across 41 related posts. The stock's rank delta of +2,388 indicates it surged dramatically in the Tendie.bot ticker rankings, reflecting a sudden spike in retail interest. With only 6 mentions but 28 comments and 12 upvotes, the conversation was concentrated but enthusiastic.
No same-day news articles were ingested for GOSS, meaning the price move was almost entirely driven by retail discussion and the Reddit post's viral effect. This is a classic example of a penny stock gaining momentum through social proof and a simple, compelling story.
Subscribe to Tendie.bot for more market recaps.